Global Multi Cancer Screening Market Growth (Status and Outlook) 2026-2032

August 2026 | 112 pages | ID: G8BC247B24A6EN
LP Information

Abstracts

The global Multi Cancer Screening market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Multi Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Multi Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Multi Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Multi Cancer Screening players cover Guardant Health, GRAIL, Burning Rock, Thermo Fisher Scientific, Exact Sciences Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Multi Cancer Screening Industry Forecast” looks at past sales and reviews total world Multi Cancer Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Multi Cancer Screening sales for 2026 through 2032. With Multi Cancer Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multi Cancer Screening industry.

This Insight Report provides a comprehensive analysis of the global Multi Cancer Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Multi Cancer Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multi Cancer Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multi Cancer Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multi Cancer Screening.

This report presents a comprehensive overview, market shares, and growth opportunities of Multi Cancer Screening market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Laboratory Developed Tests (LDTs)
• In-Vitro Diagnostics (IVDs)

Segmentation by Application:

• Hospitals
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Guardant Health
• GRAIL
• Burning Rock
• Thermo Fisher Scientific
• Exact Sciences Corporation
• Fulgent Genetics
• Genecast Biotechnology
• Agilent Technologies
• Atara Biotherapeutics
• Konica Minolta
• Tempus
• Myriad Genetics
• Laboratory Corporation

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
    2.1.1 Global Multi Cancer Screening Market Size (2021-2032)
    2.1.2 Multi Cancer Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
    2.1.3 World Current & Future Analysis for Multi Cancer Screening by Country/Region (2021, 2025 & 2032)
  2.2 Multi Cancer Screening Segment by Type
    2.2.1 Laboratory Developed Tests (LDTs)
    2.2.2 In-Vitro Diagnostics (IVDs)
    2.2.3 Multi Cancer Screening Market Size by Type
      2.2.3.1 Multi Cancer Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
      2.2.3.2 Global Multi Cancer Screening Market Size Market Share by Type (2021-2026)
  2.3 Multi Cancer Screening Segment by Application
    2.3.1 Hospitals
    2.3.2 Clinic
    2.3.3 Multi Cancer Screening Market Size by Application
      2.3.3.1 Multi Cancer Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
      2.3.3.2 Global Multi Cancer Screening Market Size Market Share by Application (2021-2026)

3 MULTI CANCER SCREENING MARKET SIZE BY PLAYER

  3.1 Multi Cancer Screening Market Size Market Share by Player
    3.1.1 Global Multi Cancer Screening Revenue by Player (2021-2026)
    3.1.2 Global Multi Cancer Screening Revenue Market Share by Player (2021-2026)
  3.2 Global Multi Cancer Screening Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
    3.3.1 Competition Landscape Analysis
    3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 MULTI CANCER SCREENING BY REGION

  4.1 Multi Cancer Screening Market Size by Region (2021-2026)
  4.2 Global Multi Cancer Screening Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Multi Cancer Screening Market Size Growth (2021-2026)
  4.4 APAC Multi Cancer Screening Market Size Growth (2021-2026)
  4.5 Europe Multi Cancer Screening Market Size Growth (2021-2026)
  4.6 Middle East & Africa Multi Cancer Screening Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Multi Cancer Screening Market Size by Country (2021-2026)
  5.2 Americas Multi Cancer Screening Market Size by Type (2021-2026)
  5.3 Americas Multi Cancer Screening Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Multi Cancer Screening Market Size by Region (2021-2026)
  6.2 APAC Multi Cancer Screening Market Size by Type (2021-2026)
  6.3 APAC Multi Cancer Screening Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Multi Cancer Screening Market Size by Country (2021-2026)
  7.2 Europe Multi Cancer Screening Market Size by Type (2021-2026)
  7.3 Europe Multi Cancer Screening Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Multi Cancer Screening by Region (2021-2026)
  8.2 Middle East & Africa Multi Cancer Screening Market Size by Type (2021-2026)
  8.3 Middle East & Africa Multi Cancer Screening Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL MULTI CANCER SCREENING MARKET FORECAST

  10.1 Global Multi Cancer Screening Forecast by Region (2027-2032)
    10.1.1 Global Multi Cancer Screening Forecast by Region (2027-2032)
    10.1.2 Americas Multi Cancer Screening Forecast
    10.1.3 APAC Multi Cancer Screening Forecast
    10.1.4 Europe Multi Cancer Screening Forecast
    10.1.5 Middle East & Africa Multi Cancer Screening Forecast
  10.2 Americas Multi Cancer Screening Forecast by Country (2027-2032)
    10.2.1 United States Market Multi Cancer Screening Forecast
    10.2.2 Canada Market Multi Cancer Screening Forecast
    10.2.3 Mexico Market Multi Cancer Screening Forecast
    10.2.4 Brazil Market Multi Cancer Screening Forecast
  10.3 APAC Multi Cancer Screening Forecast by Region (2027-2032)
    10.3.1 China Multi Cancer Screening Market Forecast
    10.3.2 Japan Market Multi Cancer Screening Forecast
    10.3.3 Korea Market Multi Cancer Screening Forecast
    10.3.4 Southeast Asia Market Multi Cancer Screening Forecast
    10.3.5 India Market Multi Cancer Screening Forecast
    10.3.6 Australia Market Multi Cancer Screening Forecast
  10.4 Europe Multi Cancer Screening Forecast by Country (2027-2032)
    10.4.1 Germany Market Multi Cancer Screening Forecast
    10.4.2 France Market Multi Cancer Screening Forecast
    10.4.3 UK Market Multi Cancer Screening Forecast
    10.4.4 Italy Market Multi Cancer Screening Forecast
    10.4.5 Russia Market Multi Cancer Screening Forecast
  10.5 Middle East & Africa Multi Cancer Screening Forecast by Region (2027-2032)
    10.5.1 Egypt Market Multi Cancer Screening Forecast
    10.5.2 South Africa Market Multi Cancer Screening Forecast
    10.5.3 Israel Market Multi Cancer Screening Forecast
    10.5.4 Turkey Market Multi Cancer Screening Forecast
  10.6 Global Multi Cancer Screening Forecast by Type (2027-2032)
  10.7 Global Multi Cancer Screening Forecast by Application (2027-2032)
    10.7.1 GCC Countries Market Multi Cancer Screening Forecast

11 KEY PLAYERS ANALYSIS

  11.1 Guardant Health
    11.1.1 Guardant Health Company Information
    11.1.2 Guardant Health Multi Cancer Screening Product Offered
    11.1.3 Guardant Health Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.1.4 Guardant Health Main Business Overview
    11.1.5 Guardant Health Latest Developments
  11.2 GRAIL
    11.2.1 GRAIL Company Information
    11.2.2 GRAIL Multi Cancer Screening Product Offered
    11.2.3 GRAIL Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.2.4 GRAIL Main Business Overview
    11.2.5 GRAIL Latest Developments
  11.3 Burning Rock
    11.3.1 Burning Rock Company Information
    11.3.2 Burning Rock Multi Cancer Screening Product Offered
    11.3.3 Burning Rock Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.3.4 Burning Rock Main Business Overview
    11.3.5 Burning Rock Latest Developments
  11.4 Thermo Fisher Scientific
    11.4.1 Thermo Fisher Scientific Company Information
    11.4.2 Thermo Fisher Scientific Multi Cancer Screening Product Offered
    11.4.3 Thermo Fisher Scientific Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.4.4 Thermo Fisher Scientific Main Business Overview
    11.4.5 Thermo Fisher Scientific Latest Developments
  11.5 Exact Sciences Corporation
    11.5.1 Exact Sciences Corporation Company Information
    11.5.2 Exact Sciences Corporation Multi Cancer Screening Product Offered
    11.5.3 Exact Sciences Corporation Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.5.4 Exact Sciences Corporation Main Business Overview
    11.5.5 Exact Sciences Corporation Latest Developments
  11.6 Fulgent Genetics
    11.6.1 Fulgent Genetics Company Information
    11.6.2 Fulgent Genetics Multi Cancer Screening Product Offered
    11.6.3 Fulgent Genetics Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.6.4 Fulgent Genetics Main Business Overview
    11.6.5 Fulgent Genetics Latest Developments
  11.7 Genecast Biotechnology
    11.7.1 Genecast Biotechnology Company Information
    11.7.2 Genecast Biotechnology Multi Cancer Screening Product Offered
    11.7.3 Genecast Biotechnology Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.7.4 Genecast Biotechnology Main Business Overview
    11.7.5 Genecast Biotechnology Latest Developments
  11.8 Agilent Technologies
    11.8.1 Agilent Technologies Company Information
    11.8.2 Agilent Technologies Multi Cancer Screening Product Offered
    11.8.3 Agilent Technologies Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.8.4 Agilent Technologies Main Business Overview
    11.8.5 Agilent Technologies Latest Developments
  11.9 Atara Biotherapeutics
    11.9.1 Atara Biotherapeutics Company Information
    11.9.2 Atara Biotherapeutics Multi Cancer Screening Product Offered
    11.9.3 Atara Biotherapeutics Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.9.4 Atara Biotherapeutics Main Business Overview
    11.9.5 Atara Biotherapeutics Latest Developments
  11.10 Konica Minolta
    11.10.1 Konica Minolta Company Information
    11.10.2 Konica Minolta Multi Cancer Screening Product Offered
    11.10.3 Konica Minolta Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.10.4 Konica Minolta Main Business Overview
    11.10.5 Konica Minolta Latest Developments
  11.11 Tempus
    11.11.1 Tempus Company Information
    11.11.2 Tempus Multi Cancer Screening Product Offered
    11.11.3 Tempus Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.11.4 Tempus Main Business Overview
    11.11.5 Tempus Latest Developments
  11.12 Myriad Genetics
    11.12.1 Myriad Genetics Company Information
    11.12.2 Myriad Genetics Multi Cancer Screening Product Offered
    11.12.3 Myriad Genetics Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.12.4 Myriad Genetics Main Business Overview
    11.12.5 Myriad Genetics Latest Developments
  11.13 Laboratory Corporation
    11.13.1 Laboratory Corporation Company Information
    11.13.2 Laboratory Corporation Multi Cancer Screening Product Offered
    11.13.3 Laboratory Corporation Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
    11.13.4 Laboratory Corporation Main Business Overview
    11.13.5 Laboratory Corporation Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Multi Cancer Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Multi Cancer Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Laboratory Developed Tests (LDTs)
Table 4. Major Players of In-Vitro Diagnostics (IVDs)
Table 5. Multi Cancer Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Multi Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Multi Cancer Screening Market Size Market Share by Type (2021-2026)
Table 8. Multi Cancer Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Multi Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Multi Cancer Screening Market Size Market Share by Application (2021-2026)
Table 11. Global Multi Cancer Screening Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Multi Cancer Screening Revenue Market Share by Player (2021-2026)
Table 13. Multi Cancer Screening Key Players Head office and Products Offered
Table 14. Multi Cancer Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Multi Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Multi Cancer Screening Market Size Market Share by Region (2021-2026)
Table 19. Global Multi Cancer Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Multi Cancer Screening Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Multi Cancer Screening Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Multi Cancer Screening Market Size Market Share by Country (2021-2026)
Table 23. Americas Multi Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Multi Cancer Screening Market Size Market Share by Type (2021-2026)
Table 25. Americas Multi Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Multi Cancer Screening Market Size Market Share by Application (2021-2026)
Table 27. APAC Multi Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Multi Cancer Screening Market Size Market Share by Region (2021-2026)
Table 29. APAC Multi Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Multi Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Multi Cancer Screening Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Multi Cancer Screening Market Size Market Share by Country (2021-2026)
Table 33. Europe Multi Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Multi Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Multi Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Multi Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Multi Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Multi Cancer Screening
Table 39. Key Market Challenges & Risks of Multi Cancer Screening
Table 40. Key Industry Trends of Multi Cancer Screening
Table 41. Global Multi Cancer Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Multi Cancer Screening Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Multi Cancer Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Multi Cancer Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Guardant Health Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 46. Guardant Health Multi Cancer Screening Product Offered
Table 47. Guardant Health Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Guardant Health Main Business
Table 49. Guardant Health Latest Developments
Table 50. GRAIL Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 51. GRAIL Multi Cancer Screening Product Offered
Table 52. GRAIL Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. GRAIL Main Business
Table 54. GRAIL Latest Developments
Table 55. Burning Rock Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 56. Burning Rock Multi Cancer Screening Product Offered
Table 57. Burning Rock Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Burning Rock Main Business
Table 59. Burning Rock Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Multi Cancer Screening Product Offered
Table 62. Thermo Fisher Scientific Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. Exact Sciences Corporation Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 66. Exact Sciences Corporation Multi Cancer Screening Product Offered
Table 67. Exact Sciences Corporation Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Exact Sciences Corporation Main Business
Table 69. Exact Sciences Corporation Latest Developments
Table 70. Fulgent Genetics Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 71. Fulgent Genetics Multi Cancer Screening Product Offered
Table 72. Fulgent Genetics Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Fulgent Genetics Main Business
Table 74. Fulgent Genetics Latest Developments
Table 75. Genecast Biotechnology Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 76. Genecast Biotechnology Multi Cancer Screening Product Offered
Table 77. Genecast Biotechnology Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Genecast Biotechnology Main Business
Table 79. Genecast Biotechnology Latest Developments
Table 80. Agilent Technologies Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 81. Agilent Technologies Multi Cancer Screening Product Offered
Table 82. Agilent Technologies Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Agilent Technologies Main Business
Table 84. Agilent Technologies Latest Developments
Table 85. Atara Biotherapeutics Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 86. Atara Biotherapeutics Multi Cancer Screening Product Offered
Table 87. Atara Biotherapeutics Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Atara Biotherapeutics Main Business
Table 89. Atara Biotherapeutics Latest Developments
Table 90. Konica Minolta Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 91. Konica Minolta Multi Cancer Screening Product Offered
Table 92. Konica Minolta Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Konica Minolta Main Business
Table 94. Konica Minolta Latest Developments
Table 95. Tempus Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 96. Tempus Multi Cancer Screening Product Offered
Table 97. Tempus Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Tempus Main Business
Table 99. Tempus Latest Developments
Table 100. Myriad Genetics Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 101. Myriad Genetics Multi Cancer Screening Product Offered
Table 102. Myriad Genetics Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Myriad Genetics Main Business
Table 104. Myriad Genetics Latest Developments
Table 105. Laboratory Corporation Details, Company Type, Multi Cancer Screening Area Served and Its Competitors
Table 106. Laboratory Corporation Multi Cancer Screening Product Offered
Table 107. Laboratory Corporation Multi Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Laboratory Corporation Main Business
Table 109. Laboratory Corporation Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Multi Cancer Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Multi Cancer Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Multi Cancer Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Multi Cancer Screening Sales Market Share by Country/Region (2025)
Figure 8. Multi Cancer Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Multi Cancer Screening Market Size Market Share by Type in 2025
Figure 10. Multi Cancer Screening in Hospitals
Figure 11. Global Multi Cancer Screening Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Multi Cancer Screening in Clinic
Figure 13. Global Multi Cancer Screening Market: Clinic (2021-2026) & ($ millions)
Figure 14. Global Multi Cancer Screening Market Size Market Share by Application in 2025
Figure 15. Global Multi Cancer Screening Revenue Market Share by Player in 2025
Figure 16. Global Multi Cancer Screening Market Size Market Share by Region (2021-2026)
Figure 17. Americas Multi Cancer Screening Market Size 2021-2026 ($ millions)
Figure 18. APAC Multi Cancer Screening Market Size 2021-2026 ($ millions)
Figure 19. Europe Multi Cancer Screening Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Multi Cancer Screening Market Size 2021-2026 ($ millions)
Figure 21. Americas Multi Cancer Screening Value Market Share by Country in 2025
Figure 22. United States Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Multi Cancer Screening Market Size Market Share by Region in 2025
Figure 27. APAC Multi Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 28. APAC Multi Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 29. China Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. India Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Multi Cancer Screening Market Size Market Share by Country in 2025
Figure 36. Europe Multi Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 37. Europe Multi Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 38. Germany Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 39. France Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Multi Cancer Screening Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Multi Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Multi Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Multi Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 52. APAC Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 53. Europe Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 55. United States Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 56. Canada Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 57. Mexico Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 58. Brazil Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 59. China Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 60. Japan Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 61. Korea Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 63. India Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 64. Australia Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 65. Germany Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 66. France Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 67. UK Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 68. Italy Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 69. Russia Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 70. Egypt Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 71. South Africa Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 72. Israel Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 73. Turkey Multi Cancer Screening Market Size 2027-2032 ($ millions)
Figure 74. Global Multi Cancer Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Multi Cancer Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Multi Cancer Screening Market Size 2027-2032 ($ millions)